Requirement for BE (Bioequivalent) study for submission to VDA (Vietnam Drug Administration)
According to Circular No. 22/2009/TT-BYT dated November 24, 2009 of the Vietnam Ministry of Health on registration of drugs, for some specific product, apart from ACTD dossier, it is also requested to submit BE study to VDA for evaluation.
BE study is considered along with ACTD dossier. Visa number could only be granted for the product if both BE study and ACTD dossier is accepted by VDA
The BE (bioequivalent) studies should be conducted according to following regulation:
Circular No. 08/2010/TT-BYT dated 26 April 2010 regarding guideilnes for reporting research data of bioavailability/bioequivalence of drug registration. BE studies should be conducted in BE study center that meet GLP and GCP standard. The certificate of GLP and GCP should be submitted to VDA for evaluation
Article 4. Provisions for research bioavailability / bioequivalence
1. Research must be designed and implemented in accordance with the study guide of bioavailability / bioequivalence study of ASEAN or the similar guidance of other organizations (such as the World Health organization (WHO) , International Conference on harmony (ICH), the U.S. Food Drug Administration (U.S. FDA)). For studies conducted in Vietnam, before conducting the research, research proposals must be evaluated and approved by specialized technical agencies authorized by the Ministry of Health.
(For Asean Guidelines for the conduct of Bioavailability and Bioequivalence studies, Please click here)
List of active ingredients that need to have bioequivalent study in registration dossier
|
No.
|
Active ingredient
|
Reference product (dosage form – strength/concentration) |
Manufacturer (country of manufacturer – country of licensing) |
|
1 |
Amlodipin |
Amlor- Capsule 5mg. |
Pfizer PGM (France) |
|
2 |
Azithromycin |
Zithromax- Powder for oral suspension 200mg/5ml |
Pfizer Italia (Italia) |
|
3 |
Carbamazepin |
Tegretol- Tablet 200mg.
|
Novatis Pharma S.p.A (Italia) |
|
4 |
Cefixim |
Oroken*- Film coated tablet 200mg; Powder for oral suspension 40mg/ 5ml và 100mg/ 5ml ; Granule for oral suspension 40mg và 100mg. |
Famar Lyon (France) |
|
5 |
Cefuroxim Axetil |
Zinnat- Film coated tablet 125mg, 500mg |
Glaxo Operation UK Ltd. (UK) |
|
6 |
Clarithromycin |
Klacid- Film coated tablet 250mg, 500mg. Klacid- Granule for oral suspension 125mg/5ml. |
Abbott Laboratories Ltd. (UK) PT Abbott Indonesia (Indonesia) |
|
7 |
Glibenclamid |
Daonil** - Tablet 5mg |
Aventis Pharma (Japan) |
|
8 |
Gliclazid |
Diamicron- Tablet 80mg.
|
Les Laboratoires Servier Industrie (France) |
|
9 |
Metformin |
Glucophage- Film coated tablet 500mg, 850mg, 1000mg. |
Merck Sante s.a.s. (France) |
|
10 |
Metoprolol |
Betaloc- Tablet 50mg. |
AstraZeneca (Philipine) |
|
11 |
Nifedipin |
Adalat- Softgel 10mg. |
R.P. Scherer GmbH & Co. Germany (Germany) |
|
|
|
Adalat*- Softgel 5mg, |
Bayer Health Care (Germany) |
|
12 |
Rifampicin |
Rimactane*- Tablet 150mg. |
Novatis (Switzerland) |
* This product is not circulated in Vietnam. The product is bought from the manufacturing country.
** This product is not circulated in Vietnam. The product is bought from the licensing country

